Assignee
EMPIRICO INC
US·10 granted patents·30 pending applications·16 citations·filing 2019–2025
Top patents by PatentIndex Score
40 records- 0196US11879125B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Jan 23, 2024·3 cites·20 claims
- 0296US11116778B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2020·Granted Sep 14, 2021·9 cites·9 claims
- 0394US11377658B2Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseasesEMPIRICO INC·Filed 2021·Granted Jul 5, 2022·2 cites·20 claims
- 0490US10941404B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2020·Granted Mar 9, 2021·2 cites·20 claims
- 0584US2025090559A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2024·Application pending·0 cites
- 0682US12258564B2GalNAc compositions for improving siRNA bioavailabilityEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·20 claims
- 0779US2023248752A1Prodrugs of alox-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2023·Application pending·0 cites
- 0878US12258563B2Modified oligonucleotidesEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 0978US2025228883A1Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related ConditionsEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1076US12312586B2Treatment of MST1 related diseases and disordersEMPIRICO INC·Filed 2024·Granted May 27, 2025·0 cites·8 claims
- 1175US11666588B2Prodrugs of ALOX-15 inhibitors and methods of using the sameEMPIRICO INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 1275US2024392295A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1375US2025197863A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1474US2026091053A1Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcriptsEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1574US2024287523A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2024·Application pending·0 cites
- 1673US2023074280A1Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcriptsEMPIRICO INC·Filed 2022·Application pending·0 cites
- 1769US11452738B2Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcriptsEMPIRICO INC·Filed 2020·Granted Sep 27, 2022·0 cites·15 claims
- 1869US2026055410A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2025·Application pending·0 cites
- 1969US2022340907A1Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2068US2024175031A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2164US2025197859A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2263US12378556B2Treatment of angiopoietin like 7 (ANGPTL7) related diseasesEMPIRICO INC·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 2362US2024279663A1Treatment of angptl4 related diseasesEMPIRICO INC·Filed 2022·Application pending·0 cites
- 2462US2025195555A1Treatment of hgfac related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2562US2025250568A1Modified oligonucleotidesEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2661US2024018523A1Galnac compositions for improving sirna bioavailabilityEMPIRICO INC·Filed 2021·Application pending·0 cites
- 2761US2025327127A1Small molecule treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 2861US2025313841A1Treatment of mst1 related diseases and disordersEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2961US2025333732A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3059US2025368990A1Treatment of ms4a4e related diseases and disordersEMPIRICO INC·Filed 2023·Application pending·0 cites
- 3157US2021361693A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
- 3257US2023357774A1Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseasesEMPIRICO INC·Filed 2021·Application pending·0 cites
- 3356US2025043281A1Treatment of fgg related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3456US2024287519A1Treatment of dkk2 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3555US2024287518A1Treatment of mtres1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3655US2024392299A1Treatment of mst1r related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3753US2024254492A1Modulation of coasy expressionEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3851US2024287517A1Treatment of plin1 related diseases and disordersEMPIRICO INC·Filed 2022·Application pending·0 cites
- 3950US2023407299A1Treatment of sos2 related diseases and disordersEMPIRICO INC·Filed 2021·Application pending·0 cites
- 4050US2022056444A1Process to inhibit or eliminate eosinophilic diseases of the airway and related conditionsEMPIRICO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMPIRICO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →